by Laskin, J.J. et al.
BC Cancer Centre, Vancouver, British Columbia, Canada
BC Cancer Centre, Vancouver, British Columbia, Canada
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer.
J. Thorac. Oncol. 2012; 3:579-86
